Literature DB >> 16091625

Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation.

Inna Nusinzon1, Curt M Horvath.   

Abstract

Histone deacetylation enzymes have often been associated with the suppression of eukaryotic gene transcription. In contrast, recent studies of inducible gene regulation indicate that protein deacetylation can also be required as a transcriptional activation signal. The concept of protein deacetylation as a requirement for transcription activation seems to contradict earlier conclusions about the function of deacetylation in gene suppression. However, in the context of a more global interpretation, these opposing effects of deacetylation imply its dynamic role in the overall control of gene expression. The exact requirement for deacetylation differs among promoters, depending on their specific architecture and regulation scenario.

Mesh:

Substances:

Year:  2005        PMID: 16091625     DOI: 10.1126/stke.2962005re11

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  39 in total

1.  Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation.

Authors:  Jailal N G Ablack; Michael Cohen; Gobi Thillainadesan; Gregory J Fonseca; Peter Pelka; Joe Torchia; Joe S Mymryk
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells.

Authors:  Shalini A Muralidhar; Valya Ramakrishnan; Inderdeep S Kalra; Wei Li; Betty S Pace
Journal:  J Biol Chem       Date:  2010-11-13       Impact factor: 5.157

3.  Negative and positive regulation of gene expression by mouse histone deacetylase 1.

Authors:  Gordin Zupkovitz; Julia Tischler; Markus Posch; Iwona Sadzak; Katrin Ramsauer; Gerda Egger; Reinhard Grausenburger; Norbert Schweifer; Susanna Chiocca; Thomas Decker; Christian Seiser
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

4.  FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Kathryn Bembas; Ran Tao; Samik Basu; James L Riley; Wayne W Hancock; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

Review 5.  Genetic and epigenetic mechanisms of gene regulation during lens development.

Authors:  Ales Cvekl; Melinda K Duncan
Journal:  Prog Retin Eye Res       Date:  2007-07-28       Impact factor: 21.198

6.  Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms.

Authors:  Takuma Uo; Timothy D Veenstra; Richard S Morrison
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

7.  Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation.

Authors:  Inna Nusinzon; Curt M Horvath
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.

Authors:  Frederick A Schroeder; Krista L Penta; Anouch Matevossian; Sara R Jones; Christine Konradi; Andrew R Tapper; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

9.  Nonconventional initiation complex assembly by STAT and NF-kappaB transcription factors regulates nitric oxide synthase expression.

Authors:  Matthias Farlik; Benjamin Reutterer; Christian Schindler; Florian Greten; Claus Vogl; Mathias Müller; Thomas Decker
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

10.  Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.

Authors:  Camille Brochier; Gretel Dennis; Mark A Rivieccio; Kathryn McLaughlin; Giovanni Coppola; Rajiv R Ratan; Brett Langley
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.